Project measures / variables set:   Graham1   CD8_spleen

ID, description, units MPD:63349   CD8_spleen   percentage of CD3+ T cells that are CD8+ in spleen, post infection   [%]  
West Nile virus study
Measures • day 7    • day 12    • day 21    • day 28
Data set, strains Graham1   CC RIX   2 strains     sex: m     age: 8-10wks
Procedure immune cell quantification
Comparisontimecourse but different cohorts
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Graham1 - percentage of CD3+ T cells that are CD8+ in spleen, post infection





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 3 6.4546 2.1515 0.0541 0.9828
strain 1 2664.9338 2664.9338 66.9862 < 0.0001
group:strain 3 152.9346 50.9782 1.2814 0.3146
Residuals 16 636.5333 39.7833

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Graham1 63349 immune cell quantification West Nile virus percentage of CD3+ T cells that are CD8+ in spleen, post infection   [%]   day 7  CD8_spleen_d7 CC RIX 2 m 8-10wks
Graham1 63350 immune cell quantification West Nile virus percentage of CD3+ T cells that are CD8+ in spleen, post infection   [%]   day 12  CD8_spleen_d12 CC RIX 2 m 8-10wks
Graham1 63351 immune cell quantification West Nile virus percentage of CD3+ T cells that are CD8+ in spleen, post infection   [%]   day 21  CD8_spleen_d21 CC RIX 2 m 8-10wks
Graham1 63352 immune cell quantification West Nile virus percentage of CD3+ T cells that are CD8+ in spleen, post infection   [%]   day 28  CD8_spleen_d28 CC RIX 2 m 8-10wks